Αποτελέσματα Αναζήτησης
Latest enhanced and revised set of guidelines. ESMO has Clinical Practice Guidelines on the following Haematological Malignancies: Acute lymphoblastic leukaemia, Acute myeloblastic leukaemia in adult patients, Chronic lymphocytic leukaemia, Chronic myeloid leukaemia, Diffuse large B cell lymphoma, Elderly patients with malignant lymphoma ...
25 Ιουν 2021 · Overall sensitivity in cancers of the blood, such as lymphoma and myeloma, was 55.1%. In addition, the multi-cancer early detection test correctly identified the tissue in which the cancer was located in the body in 88.7% of cases. Dr Klein said: “We believe that cancers that shed more cfDNA into the bloodstream are detected more easily.
According to two international studies presented at the ESMO Congress 2024, women who breastfeed after receiving treatment for breast cancer, including those with a germline BRCA mutation (an inherited change in BRCA genes that significantly increases the risk of developing certain cancers, especially breast cancer), do not face an increased risk of recurrence or developing new breast cancers
11 Σεπ 2022 · New tests can detect common cancer signal across over 50 types of cancer from tumour DNA in blood. Latest results are an important first step to early detection of previously hard to find cancers. Cancer services must step up to redefine early cancer detection and the provision of care. Date: 11 Sep 2022. Topics:
The ESMO Clinical Practice Guidelines on Early and Metastatic Breast Cancer cover information on screening, diagnosis, pathology and molecular biology, staging and risk assessment, disease management, monitoring and follow-up, palliative care and the patient perspective. There are also specific guidelines focusing on risk reduction and ...
Salivary gland cancer: ESMO–EURACAN Clinical Practice Guideline for diagnosis, treatment and follow-up. Published online: 02 November 2022. van Herpen C, Vander Poorten V, Skalova A, et al, on behalf of the ESMO Guidelines Committee. This ESMO-EURACAN Clinical Practice Guideline provides key recommendations for managing salivary gland cancer.
Biliary tract cancer is a cancer that forms in the cells of the bile ducts, gallbladder or ampulla of Vater. Cancer of the bile ducts is called cholangiocarcinoma and is classified depending on which part of the bile duct the cancer develops into intrahepatic (affects bile ducts within the liver), hilar (occurs at the junction of the left and ...
Biliary tract cancer is most common between the ages of 60 and 70. Biliary tract cancer is relatively uncommon, accounting for less than 1% of all human cancers. It is most commonly diagnosed in people between the ages of 60 and 70 years and affects slightly more men than women. (Valle et al., 2016).
Myelodysplastic syndromes (MDS) are clonal haematopoietic stem cell (HSC) disorders predominating in the elderly, with a median age at diagnosis of ~70 years. This ESMO Clinical Practice Guideline provides key recommendations for managing myelodysplastic syndromes. It covers diagnosis, classification, staging and risk assessment of ...
This ESMO Clinical Practice Guideline provides key recommendations for managing cancer-related cachexia. It covers screening, assessment and multimodal management of cancer cachexia. All recommendations were compiled by a multidisciplinary group of experts. Recommendations are based on available scientific data and the author’s expert opinion.
